153 related articles for article (PubMed ID: 36266179)
21. Implementation of sacral neuromodulation for urinary indications. A Danish prospective study during the initial 15 months of a new service in a tertiary referral hospital.
Kobberø H; Andersen M; Andersen K; Pedersen TB; Poulsen MH
Scand J Urol; 2022; 56(5-6):404-411. PubMed ID: 36085579
[TBL] [Abstract][Full Text] [Related]
22. Remotely programmed sacral neuromodulation for the treatment of patients with refractory overactive bladder: a prospective randomized controlled trial evaluating the safety and efficacy of a novel sacral neuromodulation device.
Zhang Y; Zhang P; Tian X; Chen G; Li Y; Zhang Y; Xu Z; Wei Z; Zhang W; Ma L; Shi B; Liao L; Wang J
World J Urol; 2019 Nov; 37(11):2481-2492. PubMed ID: 30809700
[TBL] [Abstract][Full Text] [Related]
23. Five-Year Followup Results of a Prospective, Multicenter Study of Patients with Overactive Bladder Treated with Sacral Neuromodulation.
Siegel S; Noblett K; Mangel J; Bennett J; Griebling TL; Sutherland SE; Bird ET; Comiter C; Culkin D; Zylstra S; Kan F; Berg KC
J Urol; 2018 Jan; 199(1):229-236. PubMed ID: 28709886
[TBL] [Abstract][Full Text] [Related]
24. [Results of sacral nerve modulation for treatment of overactive bladder].
Braun PM; Böhler G
Urologe A; 2006 Jul; 45(7):835-40. PubMed ID: 16773383
[TBL] [Abstract][Full Text] [Related]
25. Using electroacupuncture with optimized acupoint positioning to predict the efficacy of sacral neuromodulation of refractory overactive bladder: A case report.
Shen J; Luo R; Zhang L; Li Y; Ke L; Gao Z
Medicine (Baltimore); 2019 Nov; 98(45):e17795. PubMed ID: 31702631
[TBL] [Abstract][Full Text] [Related]
26. The role of neuromodulation in patients with neurogenic overactive bladder.
Lay AH; Das AK
Curr Urol Rep; 2012 Oct; 13(5):343-7. PubMed ID: 22865208
[TBL] [Abstract][Full Text] [Related]
27. What uro-gynecologists should know about sacral neuromodulation (SNM) for the treatment of refractory overactive bladder.
Oelke M; Addali M; Reisenauer C
Arch Gynecol Obstet; 2019 May; 299(5):1243-1252. PubMed ID: 30941558
[TBL] [Abstract][Full Text] [Related]
28. Sacral nerve stimulation for voiding dysfunction: One institution's 11-year experience.
Sutherland SE; Lavers A; Carlson A; Holtz C; Kesha J; Siegel SW
Neurourol Urodyn; 2007; 26(1):19-28; discussion 36. PubMed ID: 17078071
[TBL] [Abstract][Full Text] [Related]
29. Patients with Sacral Neuromodulation: What Are the Factors Affecting Their Therapy Satisfaction?
Banakhar M; Hassouna M
Urol Int; 2019; 103(4):450-453. PubMed ID: 31574517
[TBL] [Abstract][Full Text] [Related]
30. Optimal Lead Positioning in Sacral Neuromodulation: Which Factors Are Related to Treatment Outcome?
Jairam R; Marcelissen T; van Koeveringe G; van Kerrebroeck P
Neuromodulation; 2017 Dec; 20(8):830-835. PubMed ID: 28877395
[TBL] [Abstract][Full Text] [Related]
31. [Sacral neuromodulation in urology. The emperor's new clothes or effective high-tech medicine?].
Hoda MR; Fornara P
Urologe A; 2010 Oct; 49(10):1254-9. PubMed ID: 20859609
[TBL] [Abstract][Full Text] [Related]
32. Comparative Efficacy of Neuromodulation Technologies for Overactive Bladder in Adults: A Network Meta-Analysis of Randomized Controlled Trials.
Huang J; Fan Y; Zhao K; Yang C; Zhao Z; Chen Y; Yang J; Wang T; Qu Y
Neuromodulation; 2023 Dec; 26(8):1535-1548. PubMed ID: 35989159
[TBL] [Abstract][Full Text] [Related]
33. Cognitive impairment does not impact sacral neuromodulation implant rates for overactive bladder.
Zillioux J; Lewis KC; Hettel D; Goldman HB; Vasavada SP; Gill BC
Neurourol Urodyn; 2023 Mar; 42(3):623-630. PubMed ID: 36701189
[TBL] [Abstract][Full Text] [Related]
34. Sacral Neuromodulation Changes Pelvic Floor Activity in Overactive Bladder Patients-Possible New Insights in Mechanism of Action: A Pilot Study.
Voorham J; Vaganée D; Voorham-van der Zalm P; Lycklama À Nijeholt G; Putter H; De Wachter S
Neuromodulation; 2022 Dec; 25(8):1180-1186. PubMed ID: 34547159
[TBL] [Abstract][Full Text] [Related]
35. Sacral Neuromodulation with the InterStim™ System for Intractable Lower Urinary Tract Dysfunctions (SOUNDS): Results of Clinical Effectiveness, Quality of Life, Patient-Reported Outcomes and Safety in a French Multicenter Observational Study.
Chartier-Kastler E; Le Normand L; Ruffion A; Dargent F; Braguet R; Saussine C; Tanneau Y; Graziana JP; Ragni E; Rabut B; Rousseau T; Biardeau X; Gamé X; Pierrevelcin J; Brassart E; Fourmarier M; Stoica G; Berrogain N; Yaghi N; Pecoux F; Capon G; Ferchaud J; Peyrat L; Bryckaert PE; Karsenty G; Melotti A; Abouihia A; Keller DUJ; Cornu JN
Eur Urol Focus; 2021 Nov; 7(6):1430-1437. PubMed ID: 32907782
[TBL] [Abstract][Full Text] [Related]
36. Medium-term outcomes of sacral neuromodulation in patients with refractory overactive bladder: A retrospective single-institution study.
Kaaki B; Gupta D
PLoS One; 2020; 15(7):e0235961. PubMed ID: 32645082
[TBL] [Abstract][Full Text] [Related]
37. Neuromodulation for Overactive Bladder Symptoms in Women Utilizing Either Motor or Sensory/Motor Provocation With a Minimum Nine-Year Follow-Up.
Marinkovic SP; Gillen LM; Marinkovic CM
Neuromodulation; 2015 Aug; 18(6):517-21; discussion 521. PubMed ID: 25919573
[TBL] [Abstract][Full Text] [Related]
38. The Value of Ambulatory Urodynamics in the Evaluation of Treatment Effect of Sacral Neuromodulation.
Drossaerts J; Rademakers KLJ; Rahnama'i SM; Marcelissen T; Van Kerrebroeck P; van Koeveringe G
Urol Int; 2019; 102(3):299-305. PubMed ID: 30612126
[TBL] [Abstract][Full Text] [Related]
39. Screening for depression and anxiety in patients with storage or voiding dysfunction: A retrospective cohort study predicting outcome of sacral neuromodulation.
Drossaerts J; Vrijens D; Leue C; Schilders I; Van Kerrebroeck P; van Koeveringe G
Neurourol Urodyn; 2016 Nov; 35(8):1011-1016. PubMed ID: 26351817
[TBL] [Abstract][Full Text] [Related]
40. Sacral Neuromodulation with the InterStim System for Overactive Bladder: 3-Year Results from the French Prospective, Multicenter, Observational SOUNDS Study.
Chartier-Kastler E; Normand LL; Ruffion A; Saussine C; Braguet R; Rabut B; Ragni E; Perrouin-Verbe MA; Pierrevelcin J; Rousseau T; Gamé X; Tanneau Y; Dargent F; Biardeau X; Graziana JP; Stoica G; Brassart E; Fourmarier M; Yaghi N; Capon G; Ferchaud J; Berrogain N; Peyrat L; Pecoux F; Bryckaert PE; Melotti A; Abouihia A; Keller DUJ; Cornu JN
Eur Urol Focus; 2022 Sep; 8(5):1399-1407. PubMed ID: 34334342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
